MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo Nephro Sep 18-20, 2026

MER Internal Medicine for Primary Care Cardio Endo Nephro 2026 is a comprehensive continuing medical education (CME) program covering essential updates in cardiology, endocrinology, and nephrology for primary care physicians and medical specialists.

Course Overview

The MER Primary Care Conferences Internal Medicine for Primary Care: Cardiology/Endocrinology/Nephrology 2026 program, organized by Medical Education Resources (MER), provides an evidence-based review of common and complex medical conditions encountered in primary care and internal medicine practice.

Held September 18–20, 2026, at The Ritz-Carlton, Laguna Niguel, California, this educational conference emphasizes practical diagnostic approaches, clinical decision-making, disease prevention, and contemporary treatment strategies.

The program addresses major clinical topics including cardiovascular disease prevention, coronary artery disease, heart failure, atrial fibrillation, osteoporosis, calcium metabolism disorders, chronic kidney disease, diabetic nephropathy, glomerulonephritis, and electrolyte abnormalities.

Through case-based discussions and guideline-focused presentations, healthcare professionals can strengthen their understanding of clinical management across three closely connected medical specialties.

Course Details

• Course Title: MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo Nephro Sep 18-20, 2026
• Organizer: Medical Education Resources (MER)
• Conference Dates: September 18–20, 2026
• Location: The Ritz-Carlton, Laguna Niguel, Laguna Beach, California, USA
• Specialties: Internal Medicine, Cardiology, Endocrinology, Nephrology
• Educational Format: Continuing Medical Education Conference
• Original Conference Credit Designation: Up to 12 AMA PRA Category 1 Credits™ for eligible participation in the live activity
• Language: English

The original conference accreditation does not imply that purchasing educational materials separately provides CME credits.

Target Audience

This program is designed for healthcare professionals seeking clinical updates in internal medicine and primary care, particularly:

• Primary Care Physicians
• Internal Medicine Physicians
• Family Medicine Physicians
• Cardiologists
• Endocrinologists
• Nephrologists
• Nurse Practitioners
• Physician Assistants
• Other healthcare professionals involved in adult patient care

Program Overview

The conference integrates three major medical specialties to provide a clinically relevant educational experience.

Cardiology

Explore contemporary approaches to cardiovascular disease prevention, lipid management, coronary artery disease evaluation, heart failure treatment, and arrhythmia management.

Endocrinology

Review calcium metabolism, metabolic bone diseases, osteoporosis diagnosis and treatment, DEXA interpretation, FRAX assessment, and endocrine case management.

Nephrology

Examine chronic kidney disease management, SGLT2 inhibitor therapy, diabetic kidney disease, glomerulonephritis, and common electrolyte and acid-base disturbances.

Learning Objectives

Upon completion of this program, participants should be better able to:

1. Discuss current diagnostic criteria and treatment approaches to disorders of calcium metabolism.
2. Identify the risks and benefits of utilizing bisphosphonates in the treatment of osteoporosis.
3. Utilize case-based learning to develop treatment plans for osteoporosis.
4. Utilize case-based learning to develop treatment plans for calcium disorders.
5. Describe evidence-based guidelines for the use of SGLT2 inhibitors in patients with CKD.
6. Describe treatment options for hematuria and glomerulonephritis.
7. Identify strategies to detect and treat diabetic kidney disease.
8. Review the pathophysiology, diagnosis, prevention and management of common electrolyte imbalances.
9. Implement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD.
10. Describe the work-up, risk assessment and test selection of patients with suspected CAD.
11. Implement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure.
12. Describe current diagnostic and treatment approaches to arrhythmias and atrial fibrilation.

Official Program Topics and Conference Agenda

Day 1 — Friday, September 18, 2026

Endocrinology

1. Disorders of Calcium Metabolism

• Calcium homeostasis and regulation
• Causes of hypercalcemia
• Diagnostic evaluation of calcium abnormalities
• Treatment of calcium metabolism disorders

2. Metabolic Bone Disease

• Disorders of mineral and vitamin D metabolism
• Calcium and phosphorus regulation
• Osteomalacia and Paget’s disease
• Parathyroid disorders and bone health

3. Osteoporosis

• Epidemiology and pathophysiology of osteoporosis
• DEXA scan interpretation
• FRAX fracture risk assessment
• Current pharmacological treatment options

Nephrology

4. Should All Patients with CKD be on SGLT2 Inhibitors?

• Role of SGLT2 inhibitors in chronic kidney disease
• Kidney and cardiovascular benefits
• Guideline-directed medical therapy
• Treatment considerations in patients with and without diabetes

5. Glomerulonephritis 101

• Recognition and diagnosis of glomerulonephritis
• Differentiating glomerular diseases
• IgA nephropathy
• Emerging and approved therapeutic approaches

Day 2 — Saturday, September 19, 2026

Nephrology

6. Managing Diabetic Kidney Disease: New Insights and Therapies

• Early identification of diabetic kidney disease
• Diagnosis and progression of chronic kidney disease
• New treatment strategies
• Nonsteroidal mineralocorticoid receptor antagonists
• GLP-1 receptor agonists and kidney outcomes

7. Primary Care Primer on Electrolytes

• Sodium disorders
• Potassium imbalances
• Bicarbonate and acid-base abnormalities
• Case-based diagnosis and treatment

Endocrinology

8. Endocrinology Cases: Calcium Disorders and Osteoporosis

• Clinical case discussions
• Diagnostic and therapeutic decision-making
• Calcium abnormalities
• Individualized osteoporosis treatment planning

Cardiology

9. Primary Prevention of Cardiometabolic CVD

• Cardiovascular risk assessment
• Lipid and cholesterol guidelines
• Metabolic syndrome and obesity
• Lifestyle modification and exercise
• Preventive pharmacotherapy
• Cardiac rehabilitation

10. Work-up of Patients with Suspected CAD

• Coronary artery disease risk factors
• Chest pain evaluation
• ACC/AHA chest pain guidance
• ECG, echocardiography, and cardiac imaging
• CT-based evaluation
• Special populations with suspected CAD

Day 3 — Sunday, September 20, 2026

Cardiology

11. Heart Failure

• Heart failure classification and staging
• HFrEF and HFpEF
• ACC/AHA guideline-based management
• ACE inhibitors, ARBs, ARNI, and beta-blockers
• Mineralocorticoid receptor antagonists and SGLT2 inhibitors
• NT-proBNP and other biomarkers
• Device therapy and referral considerations
• Acute decompensated heart failure

12. Arrhythmias

• Evaluation of palpitations
• Common cardiac arrhythmias
• Atrial fibrillation diagnosis and treatment
• Stroke risk assessment
• Anticoagulation strategies
• Rate versus rhythm control
• Ventricular arrhythmias and referral indications

Major Topics Covered

• Internal Medicine Updates for Primary Care
• Cardiovascular Disease Prevention
• Coronary Artery Disease Diagnosis
• Heart Failure Management
• Atrial Fibrillation and Cardiac Arrhythmias
• Lipid and Cholesterol Management
• Calcium Metabolism Disorders
• Metabolic Bone Disease
• Osteoporosis and Fracture Risk Assessment
• Chronic Kidney Disease
• Diabetic Kidney Disease
• SGLT2 Inhibitors in CKD
• Glomerulonephritis and IgA Nephropathy
• Electrolyte and Acid-Base Disorders
• Evidence-Based Clinical Guidelines
• Case-Based Medical Decision-Making

Course Organizer

Medical Education Resources (MER)

MER provides continuing medical education activities for healthcare professionals, focusing on evidence-based clinical education, interdisciplinary learning, and practical applications in patient care.

Why This Course Is Relevant

The MER Internal Medicine for Primary Care Cardio Endo Nephro 2026 conference covers conditions frequently encountered in both general and specialist medical practice.

Its integrated approach is particularly relevant for clinicians managing patients with overlapping cardiovascular, metabolic, and renal diseases.

Key educational benefits include:

• Understanding contemporary clinical guidelines across three medical specialties.
• Improving diagnostic approaches to common endocrine and renal disorders.
• Reviewing cardiovascular risk reduction and disease management.
• Exploring emerging therapeutic options for chronic kidney disease.
• Applying evidence-based knowledge to real-world patient scenarios.
• Strengthening decision-making in multidisciplinary primary care.

This program is a valuable educational resource for physicians seeking to update their clinical knowledge in cardiology, endocrinology, nephrology, and internal medicine.

Short Description

MER Internal Medicine for Primary Care Cardio Endo Nephro 2026 delivers a focused CME educational review of cardiology, endocrinology, and nephrology, based on the September 18–20, 2026 MER Primary Care Conference in Laguna Beach, California.

Key Topics:

• Cardiology: CAD, Heart Failure, Arrhythmias, Atrial Fibrillation
• Endocrinology: Osteoporosis, Calcium Disorders, Metabolic Bone Disease
• Nephrology: CKD, SGLT2 Inhibitors, Diabetic Kidney Disease, Electrolytes
• Evidence-Based Guidelines and Clinical Case Discussions

Ideal for: Primary Care Physicians, Internists, Cardiologists, Endocrinologists, and Nephrologists.

Topics

• Disorders of Calcium Metabolism

• Osteoporosis

• Endocrinology Cases: Osteoporosis

• Should All Patients with CKD be on SGLT2 Inhibitors?

• Glomerulonephritis 101

• Managing Diabetic Kidney Disease: New Insights and Therapies

• Primary Care Primer on Electrolytes

• Endocrinology Cases: Calcium Disorders

• Primary Prevention of Cardiometabolic CVD

• Work-up of Patients with Suspected CAD

• Heart Failure

• Arrhythmias